At eNeura, we are dedicated to pioneering transformative solutions in healthcare, particularly in the field of neurology. Our esteemed Medical Advisory Board stands at the forefront of this mission, bringing together a collective of distinguished professionals and thought leaders in medicine.
As we navigate the complex landscape of neurological disorders, our advisory board plays a pivotal role in shaping the future of patient care. Comprising leading experts in neurology, neurosurgery, and related disciplines, this esteemed group provides invaluable insights, guidance, and strategic direction to ensure that eNeura remains at the cutting edge of medical innovation.
Join us on a journey into the realm of groundbreaking medical advancements as we introduce you to the individuals driving eNeura’s commitment to excellence.
Together, we are dedicated to advancing the frontiers of healthcare, enhancing patient outcomes, and revolutionizing the landscape of neurology.
Dr. Peter Goadsby’s major research interests are in the basic mechanisms of primary headache disorders, such as migraine and cluster headache, in both experimental and clinical settings, and translating these insights into their better management.
He is the Director of the National Institute for Health Research – Wellcome Trust King’s Clinical Research Facility (CRF).
The CRF provides dedicated facilities to support the delivery of externally-funded early translational, experimental medical research, including early-phase studies and early translational research studies that are nested within later-phase studies.
He leads the Biomedical Research Council Themes; Clinical Research Facility, and Pain and Headache. He is also the National Lead for Neurological Disorders for the Clinical Research Network, NIHR UK, a Trustee of the Organisation for the Understanding of Cluster Headache (OUCH UK) and Chair of the Scientific Programme Committee, Migraine Trust International Symposium.
Dr. Goadsby also leads the Pain and Addictions theme at the NIHR Maudsley Biomedical Research Centre.
Amaal J. Starling, M.D., studies primary and secondary headache disorders, including migraines and post-traumatic headaches. This includes understanding underlying pathophysiology, establishing clinical phenotypes and exploring novel therapeutics for headache disorders.
Dr. Starling participates in clinical trials exploring novel therapeutics for migraines that are more effective and better tolerated than currently available options. She has a special interest in exploring nondrug options for the treatment of migraines, including neuromodulation devices such as single-pulse transcranial magnetic stimulation.
Additionally, Dr. Starling is developing a human research model of post-traumatic headaches that will allow for the investigation of underlying pathophysiology and the development of objective biomarkers.
• Migraine. Dr. Starling participates in clinical trials to develop novel therapeutics for the treatment of migraines and other primary headache disorders. Current available treatment options are often ineffective and poorly tolerated. However, there are currently a number of novel therapeutic options, both drug and nondrug, available for clinical trial investigation. Proper investigation of these novel therapeutics, which includes appropriate use of inclusion and exclusion criteria, will ensure that these therapeutic options are viable, effective and well-tolerated and will hopefully become available for clinical use in the patient population.
• Neuromodulation. Dr. Starling studies a variety of neuromodulation devices for the treatment of migraines and other primary headache disorders as a novel, nondrug therapeutic option. Her pivotal work in single-pulse transcranial magnetic stimulation for the preventive treatment of migraines has led to a label expansion for this device for migraine prevention in adults.
• Post-traumatic headache. Dr. Starling is currently developing a human research model of post-traumatic headaches that will allow for mechanistic investigation of the underlying pathophysiology, as well as assessment of prognostic factors and efficacy of potential therapeutic interventions. She is actively evaluating light-induced visual pain threshold and heat pain threshold in patients with post-traumatic headaches.
• Advocacy. Dr. Starling is also very active in case advocacy: specifically in migraines, other primary headache disorders, post-traumatic headaches and concussions. Annually, Dr. Starling is involved with migraine advocacy organizations and events including Headache on the Hill, Miles for Migraine, the American Headache Society and the American Migraine Foundation. She is interested in exploring the tools and techniques that can be used by providers to incorporate advocacy into clinical practice.
Significance to patient care
Migraines and other headache disorders are listed by the World Health Organization as one of the most disabling diseases worldwide. Dr. Starling’s hope is that her research and advocacy will advance care for people with migraines, post-traumatic headaches and other headache disorders. She envisions a future in which all people with headache disorders receive personalized, effective and well-tolerated treatment options to improve their quality of life.
Professor of Neurology
Bio – CGRP Forum
Stewart J. Tepper, MD is Professor of Neurology at the Geisel School of Medicine at Dartmouth (Dartmouth Medical School) in Hanover, New Hampshire, USA. He is Director of the Dartmouth Headache Clinic in the Department of Neurology of Dartmouth-Hitchcock Medical Center, Lebanon, New Hampshire. Dr Tepper is Editor-in-Chief of the journal Headache Currents and Associate Editor for the journal Headache and has published over 320 peer-reviewed manuscripts, editorials, and books, including The Cleveland Clinic Manual of Headache Therapy, Second Edition (Springer, 2014).
He has been Co-Director of the Scottsdale Headache Symposium course of the American Headache Society from 2008 to the present and was Director of the Headache Therapy course for the American Academy of Neurology 2009-2011. Dr Tepper received his undergraduate degree in the study of the nervous system/Psychobiology from Yale College and attended Cornell University Medical College. He completed his Neurology residency at Harvard, and has been Board-certified in Headache Medicine since 2006.
Deena E. Kuruvilla, M.D., is a board certified neurologist and Director of the Westport Headache Institute, where she employs a holistic, biopsychosocial approach to diagnosis and treatment. She has held clinical appointments at the Yale University School of Medicine prior to starting her own practice, and has authored many articles, book chapters, and research publications.
Dr. Kuruvilla completed her medical internship at the Mount Sinai School of Medicine in New York. Subsequently, she completed her Neurology residency at Brown University in Rhode Island, where she was chief resident. She went on to complete a fellowship in Headache and Facial Pain at the Montefiore Headache Center and the Albert Einstein College of Medicine.
She is board certified in Neurology by the American Board of Psychiatry and Neurology and certified in Headache Medicine by the United Council for Neurologic Subspecialties.
Dr. Kuruvilla’s primary focus deals with the procedural side of Headache Medicine, which include nerve block injections, botulinum toxin injections and trigger point injections for the treatment of headache. She is a member of the American Academy of Neurology and American Headache Society and actively serves on the special interests sections for the procedural headache medicine section of the American Headache Society. She has also been an invited reviewer and author for many peer-reviewed publications including Headache, Cephalalgia, JAMA, and the British Medical Journal.
Dr. Kuruvilla’s research and clinical work has been widely featured in the press, including Prevention Magazine, Neurology Today, Food Network, and the Wall Street Journal.
Annika Ehrlich is a nurse practitioner who cares for patients with headache disorders. She has a special interest in holistic care, and strives to provide patient-specific options in addition to medications, including lifestyle modifications, mindfulness and meditation, exercise, healthy eating habits, aromatherapy, light therapy, and cold therapy.
In her research, Ehrlich examines treatments for migraines and other types of headaches, including inpatient infusions to for particularly difficult-to-treat headache patterns.
Ehrlich completed the master of science degree at the UCSF School of Nursing. She is certified in neuroscience nursing and has completed additional study in headache medicine from the National Headache Foundation.
Ehrlich enjoys teaching nurse practitioner students and is a volunteer assistant clinical professor in the department of family health care nursing at UCSF. She sits on the board of several headache organizations. Passionate about patient advocacy, Ehrlich has participated in events such as Headache on the Hill, a lobbying event in Washington, DC that brings together patients, health care providers and policymakers to raise awareness of headache disorders and increase funding for treatment and research.
Andrew Charles is a Professor of Neurology and the Meyer and Renee Luskin Chair in Migraine and headache studies. He is director of the UCLA Migraine and Pain Program. As director of this program, he oversees a multidisciplinary team focused on discovering basic mechanisms of migraine and pain that can be targeted by new treatments.
His laboratory uses imaging and electrophysiological techniques to investigate cellular signaling pathways involved in migraine and pain. He also leads projects involved in functional brain imaging of patients with migraine and pain. Based on their research, the program is developing new pharmacological and non-pharmacological treatment approaches.
Barbara L. Nye, M.D., has been committed to the practice of Neurology for over a decade and is currently a Neurologist, Headache Specialist, and Headache Fellowship Director at Atrium Health Wake Forest Baptist .
Dr. Nye previously served as Co-Director of the Headache Clinic at Dartmouth-Hitchcock Medical Center in Lebanon, N.H., Dr. Nye provides comprehensive services in migraine management, neurology and headaches where she make a difference in improving her patient’s quality of life. A distinguished member of the medical field, Dr. Nye has spent the last ten years perfecting her skills to ensure that each patient is treated with the utmost care and respect.
When she was 7 years old, Dr. Nye was exposed to the medical field after her sister was diagnosed with cancer. After accompanying her sister to several doctor appointments, Dr. Nye realized she wanted to be a doctor after witnessing the interactions between her sister and her medical caretakers. The kind communication between her family and doctors — combined with the way Dr. Nye was integrated into her sister’s care — led her to pursue a career in the medical field. After earning a bachelor’s degree in biology from the University of North Florida in 2004, she enrolled at the University of South Florida and earned a Doctor of Medicine degree in 2010. She immediately secured an internship at the Tampa General Hospital, where she remained for one year. By 2013, Dr. Nye completed a neurology residency at Dartmouth-Hitchcock Medical Center, and later accepted a headache fellowship at the same medical institution. After concluding the fellowship in 2015, she was offered a permanent position at Dartmouth-Hitchcock Medical Center as its co-director of the Headache Clinic. As of 2021, she is now the Headache Fellowship Program Director and educates 2 fellows per year.
Years of rigorous practice and academic training reached fruition when Dr. Nye took the helm of the Headache Clinic. She performs inpatient and outpatient care, rounds between three to five new patients daily and follows up with existing patients. She conducts extensive research — including both self-initiated research and current industry-sponsored studies — on monoclonal antibodies, CGRP small molecules and devices for migraine and cluster headaches. Additionally, she is currently working on quality improvement projects within the hospital, changing practices with lumbar punctures and improving clinical flow through EMR implementation of smart sets. Her impressive research and intelligence earned her several accolades and scholarships, including the Evelyn Shiver Scholarship in 2009, the University of South Florida Scholarship in 2010, the Scholarship to attend Multiple Sclerosis Conference’s Training Practicum for Tomorrow’s Physician Experts: Evolutions in Multiple Sclerosis Care, and most recently, a scholarship to attend the second annual International Headache Academy Meeting in Washington, D.C. She was named the Administrative Chief Resident at Dartmouth-Hitchcock Medical Center’s Department of Neurology in 2014 and received the Roy Forster Resident Teaching Award at the same medical institution in 2014.
To ensure that she remains updated on evolving breakthroughs within her field — and to share her own research — Dr. Nye is a member of several associations including the International Headache Society, the Northern New England Neurological Society, the New Hampshire Chapter of the Society for Neuroscience, the American Headache Society, the Headache Cooperative of New England, the American Medical Association and the Christian Medical and Dental Association. Although she maintains an active schedule, Dr. Nye makes time to enjoy personal endeavors including hiking with her children and dog, going to the theater and spending time outdoors. She is also an active member of Our Savior Lutheran Church.
With a successful career at hand, Dr. Nye remains humble as she attributes her success to learning from various mentors while attending the University of South Florida. She credits her tenacity for leading her to associate herself with the right people to land in the right profession. To maintain her successful career, Dr. Nye plans to conduct community outreach, expanding the headache clinic and conducting more research, gaining additional certifications and publishing more content.
Lauren R. Natbony, MD, FAHS, is the Founder & Medical Director of Integrative Headache Medicine of New York. She is also an Assistant Clinical Professor of Neurology in the Division of Headache and Facial Pain at Mount Sinai’s Icahn School of Medicine. Dr. Natbony previously served as the Director of the Headache Medicine Fellowship at Mount Sinai and continues to be actively involved in teaching headache fellows and neurology residents. She is board-certified in Neurology by the American Board of Psychiatry and Neurology and in Headache Medicine by the United Council of Neurologic Subspecialties.
Dr. Natbony received her undergraduate degree from Stanford University and her medical degree from the University of Miami Leonard M. Miller School of Medicine. She completed her internship in Internal Medicine and residency in Neurology at the University of Pittsburgh Medical Center, followed by a fellowship in Headache Medicine at the Icahn School of Medicine at Mount Sinai. Dr. Natbony also has advanced training and certification in medical acupuncture from Harvard Medical School. With this unique combination of training, she focuses on treating complex chronic headache and facial pain disorders.
Dr. Natbony is a leader in the field of Headache Medicine, reflected in her designation as a Fellow of the American Headache Society (FAHS). She also serves as the Secertary General of the World Headache Society. Dr. Natbony is a frequently invited speaker at national conferences and contributes to many magazines, news articles, textbooks and peer reviewed studies. She is consistently recognized for her excellence in patient care and has been named a Top Doctor in New York by both Castle Connolly and Superdoctors.
Dr. Natbony is an acupuncture and lifestyle medicine expert, and someone who’s suffered from migraine and headache. She lives on Long Island with her husband, two sons and their toy poodle, Tiny. She enjoys running, yoga, playing the oboe and spending time with her family and friends.
Teshamae Monteith, MD graduated from medical school at the University of Miami in 2004. While training, she developed an appreciation for the brain and an enthusiasm for the potential of clinical advances to reduce suffering. She went on to complete her neurology residency at the New York University School of Medicine in 2008.
During her subsequent fellowship at the Thomas Jefferson University Jefferson Headache Center, she developed a comprehensive approach to headache management. Dr. Monteith pursued a second fellowship at the University of California, San Francisco, from 2009 to 2011, where she was involved in research studies involving migraine and other headache disorders. Currently, she is an associate professor of clinical neurology, chief of the Headache Division, and the headache medicine fellowship director at the University of Miami’s Miller School of Medicine.
As a result of her passion for training the next generation of specialists, Dr. Monteith became the founding chair of the New Investigator and Trainee Section of the American Headache Society.
Dr. Monteith has served as a peer reviewer for several journals and grants, and she has also given regional, national, and international lectures in migraine and other headache disorders. She is on the editorial board for the American Migraine Foundation and the American Academy of Neurology’s (AAN) Brain and Life Magazine.
She is also on the editorial board for the Neurology Journal and is a senior host for the Neurology Podcast and the Neurology Minute. Dr. Monteith is the Associate Editor of the Continuum Audio podcast. She has been a guest editor for the New England Journal of Medicine Group and was featured in the Lancet Neurology’s Lifeline.
Larry Charleston IV, MD graduated in Medicine from the Wayne State University School of Medicine in Detroit, Michigan. He then completed his internship in internal medicine at St. John Hospital and Medical Center in Detroit, Michigan and neurology residency at Baylor College of Medicine in Houston, Texas.
After residency training, he completed his Headache and Facial Pain fellowship at the Thomas Jefferson Headache Center in Philadelphia, Pennsylvania. Dr. Charleston is certified in Adult Neurology by the American Board of Psychiatry and Neurology (ABPN) and Headache Medicine by the United Council of Neurological Subspecialties (UCNS). He received his MS degree in Health and Health Care Research from the National Clinical Scholars Program at the University of Michigan in Ann Arbor, Michigan in 2017. Dr. Charleston joined the Department of Neurology at Michigan State University in March 2021.
The research of Chia-Chun Chiang, M.D., pertains to all facets of the association between migraine and stroke. Dr. Chiang focuses on the management of headache in people with vascular disorders. She uses novel artificial intelligence (AI) and learning techniques to improve outcomes in patients with headache or cerebrovascular disorders.
• Studies have shown that there is an increased risk of stroke in patients with migraine and especially those who have migraine with aura. Dr. Chiang’s research focuses on studying the mechanisms behind such association. She has collaborated with Mayo Clinic Department of Cardiology and identified an association between migraine aura and atrial fibrillation using a novel AI-ECG algorithm.
• Dr. Chiang has published extensively on the management of headache in patients with various cerebrovascular disorders. This includes moyamoya disease, cavernous malformation and cerebral venous sinus thrombosis.
• Dr. Chiang has conducted extensive data research on determining headache phenotype subgroups based on an established headache database at Mayo Clinic’s campus in Rochester, Minnesota. Additionally, Dr. Chiang’s team and collaborators have developed a natural language processing model to identify migraine reported on social media.
Significance to patient care
Both migraine and stroke are leading causes of disability throughout the world. Identifying the association between migraine and stroke can help reduce the chances of developing adverse cerebrovascular and cardiovascular events in people with migraine. Currently, there are no accurate ways to predict treatment outcomes in patients with migraine. Sometimes it can take months or years before treatments are effective. Improving treatment outcomes can reduce the time and pain for many people.
Raquel Langdon, M.D., completed medical training at George Washington University School of Medicine & Health Sciences and her residency and fellowship training in child neurology through Children’s National Hospital. She currently serves as the assistant director of the Children’s National Headache Program.
Dr. Langdon’s research interests include pediatric headache disorders and co-morbid conditions, pediatric post-traumatic headache as well as pediatric concussion.
Jessica Ailani, MD, is board certified in neurology, with added certifications in neurology and headache. She sees patients at the McLean, Virginia, clinic.
Dr. Ailani is a clinical professor of neurology at MedStar’s Georgetown University Hospital and director of the MedStar Georgetown Headache Center. The conditions she treats include migraines, cluster headaches, tension headaches, post-traumatic headaches, occipital neuralgia, headache related to neck strain and concussion-related headaches. She uses a wide variety of treatment options in headache management including Botox for chronic migraine.
Dr. Ailani is involved in numerous clinical trials focused on new treatments in the migraine space..
She is dedicated to educating the field on headache disorders. She is a national and international speaker, invited to discuss migraine at headache and primary care meetings. She has spoken at the American Headache Society, Diamond Headache meeting, International Headache Society, American Academy of Neurology, American Neurological Association, and has presented abstracts at both national and internation meetings.
Because people don’t always want to take medications, Dr. Ailani is very willing to work with patients in finding lifestyle solutions. If patients want medications, she is willing to treat the headache aggressively. Dr. Ailani uses an integrative approach, with care designed around what the patient wants, encompassing all possibilities.
Dr. Ailani and her husband are from New York, and enjoy the warmer weather in the D.C. area. While others might not think of Washington as “the south,” it certainly is for these former Long Islanders. They appreciate the museums as well as the cultural mix of people and restaurants in the Washington metro area. Dr. Ailani also enjoys the diversity of patients she sees daily, coming from rural areas, the city, as well as internationally.